Begin Main Content Area


CHIP Provider Enrollment Claim Denial Alert (PDF)
Clarification of Opioid Continuing Education Requirement Under ABC-MAP* (PDF)
Evidence-Based Prescribing:  Tools You Can Use to Fight the Opioid Epidemic (PDF)
Act 6 of 2018 Reporting of Sanctions and Criminal Proceedings, Suspension and Civil Penalties (PDF)
Fentanyl Safety Recommendations (PDF)
Drug Enforcement Administration (DEA) Renewal Change
Opioid Education for Optometrists Certified to Prescribe and Administer Pharmaceutical Agents and Renewals Submitted after July 1, 2017 (PDF)

Act 31 of 2014 Mandated Child Abuse Recognition and Reporting


Department of Health Notice; Lifitegrast (Xiidra) ophthalmic solution (PDF)
Health Care Practitioner Photo Identification Badge Requirement (PDF)
Pennsylvania's New Prescription Drug Monitoring Program (PDF)
Naloxone Frequently Asked Questions (PDF)
Naloxone Prescription for Overdose Prevention (Standing Order DOH-002-2016) (PDF)
Naloxone for Opioid Safety - A Provider's Guide to Prescribing to Patients Who Use Opioids (PDF)
Naloxone Standing Order Prescription Letter for Pharmacists (PDF)
Veteran's Administration Hospitals-License Verification (PDF) 
American Board of Optometry (ABO) Board Certification (PDF) 
DEA Rescheduling Hydrocodone Products (PDF)
Notice - Act 65 of 2023 Expungement Provisions (PDF)
Drugs Approved for PA Optometrists - December​ 2023


Elder Abuse Prevention Guides


<<Previous Page